Evolving U.S. service model for patients with severe mental illness and co-occurring substance use disorder

Acta Neuropsychiatrica

Volumn 16, Issue 1, 2004, Pages 36-40

  Drake, Robert E ^a,b,e   Morse, G ^c   Brunette, M F ^a,b   Torrey, W C ^a,b,d  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^d West Central Services Inc   (United States)

^e Research Center   (United States)

Author keywords

Co occurring disorders; Dual diagnosis; Severe mental illness; Substance abuse

Indexed keywords

CLINICAL RESEARCH; COMORBIDITY; HEALTH CARE QUALITY; LEADERSHIP; MENTAL DISEASE; MENTAL HEALTH; PATIENT COUNSELING; QUALITY CONTROL; REVIEW; SUBSTANCE ABUSE; TRAINING; TREATMENT PLANNING; UNITED STATES;

EID: 1542346927     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2004.0059.x     Document Type: Review

References (39)

1. BACHRACH LL. Young adult chronic patients: An analytical review of the literature. Hosp Community Psychiatry 1982;33:189-197.
2. CATON C. The new chronic patient and the system of community care. Hosp Community Psychiatry 1981; 32:475-478.
3. PEPPER B, KRISHNER MC, RYGLEWICZ H. The young adult chronic patient: Overview of a population. Hosp Community Psychiatry 1981;32:463-469.
4. DRAKE RE, MERCER-MCFADDEN C, MUESER KT, MCHUGO GJ, BOND GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998;24:589-608.
5. DRAKE RE, ESSOCK SM, SHANER A, CAREY KB, MINKOFF K, KOLA L, LYNDE D, OSHER FC, CLARK RE, RICHARDS L. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;52:469-476.
6. REGIER DA, FARMER ME, RAE DS, LOCKE BZ, KEITH SJ, JUDD LL, GOODWIN FK. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990;264:2511-2518.
7. RIDGELY MS, OSHER FC, GOLDMAN HH, TALBOTT JA, eds. Chronic mentally ill young adults with substance abuse problems, a review of research, treatment, and training issues. Task Force on Chronic Mentally Ill Young Adults with Substance Problems. Baltimore: University of Maryland School of Medicine, Mental Health Services Research Center, 1987.
8. RIES R, ed. Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series. Rockville, MD: Substance Abuse and Mental Health Services Administration, 1994.
9. ONKEN LS, BLAINE JD, GENSER S, HORTON AM, eds. Treatment of Drug-Dependent Individuals with Comorbid Mental Disorders. NIDA Research Monograph 172. Bethesda MD: National Institute of Drug Abuse, 1997.
10. MUESER K, BELLACK A, BLANCHARD J. Comorbidity of schizophrenia and substance abuse. J Consult Clin Psychol 1992;60:845-856.
11. MINKOFF K. An integrated treatment model for dual diagnosis of psychosis and addiction. Hosp Community Psychiatry 1989;40:1031-1036.
12. Fox L. Surviving and thriving with a dual diagnosis. Understanding Stress Anxiety and Depression 1998;2:5-7.
13. CASWELL JS. Employment: A consumer's perspective. In: BECKER DR, BARCUS M, eds. Connections - State Partnership Initiative. Fairfax, VA: Virginia Commonwealth University, 2001: 5.
14. GREEN VL. The resurrection and the life. Am J Orthopsychiatry 1996;66:12-16.
15. ANTHONY WA. Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychosocial Rehab J 1993;16:11-23.
16. DEEGAN PE. Recovery: The lived experience of rehabilitation. Psychosocial Rehab J 1988;11:11-19.
17. MEAD S, COPELAND ME. What recovery means to us. Consumers' perspectives. Community Ment Health J 2000;36:315-328.
18. RAPP CA. The Strengths Model. New York, NY. Oxford University Press, Inc. 1998.
19. DRAKE RE, MUESER KT, CLARK RE, WALLACH MA. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry 1996;66:42-51.
20. CAREY KB. Substance use reduction in the context of out-patient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Ment Health J 1996;32:291-306.
21. OSHER FC KOFOED LL. Treatment of patients with psychiatric and psychoactive substance use disorders. Hosp Community Psychiatry 1989;40:1025-1030.
22. MCHUGO GJ, DRAKE RE, BURTON HL, ACKERSON TH. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. J Nerv Ment Dis 1995;183:762-767.
23. TURNER JC, TENHOOR WJ. The NIMH community support program: Pilot approach to a needed social reform. Schizophr Bull 1978;4:319-348.
24. MINKOFF K. An integrated model for the management of co-occurring psychiatric and substance disorders in managed care systems. Dis Mgt Health Outcomes 2000;8:251-257.
25. INSTITUTE OF MEDICINE. Broadening the Base of Treatment for Alcohol Problems. Washington, DC: National Academy Press, 1990.
26. TORREY WC, DRAKE RE, COHEN M, Fox LB, LYNDE D, GORMAN P, WYZIK P. The challenge of implementing and sustaining integrated dual disorders. Community Ment Health J 2002;38:507-521.
27. BRUNETTE MF, DRAKE RE. Clinician Workbook for Integrated Dual Disorders Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration U.S. Public Health Service, 2002.
28. MERCER-MCFADDEN C, DRAKE RE, BROWN NB, Fox RS. The community support program demonstrations of services for young adults with severe mental illness and substance use disorders 1987-91. Psychiatr Rehab J 1997;20:13-24.
29. BELLACK AS, DICLEMENTE CC. Treating substance abuse among patients with schizophrenia. Psychiatr Serv 1999;50:75-80.
30. MUESER KT, DRAKE RE, NOORDSY DL. Integrated mental health and substance abuse treatment for severe psychiatric disorders. J Pract Psychiatry Behav Health 1998;4:129-139.
31. ALVERSON H, ALVERSON M, DRAKE RE. An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness. Community Ment Health J 2000;36:557-569.
32. MUESER KT, Fox L. A family intervention program for dual disorders. Community Ment Health J 2002;38:253-270.
33. O'KEEFE C, POTENZA DP, MUESER KT. Treatment outcomes for severely mentally ill patients on conditional discharge to community-based treatment. J Nerv Ment Dis 1997;185:409-411.
34. BRUNETTE MF, DRAKE RE, WOODS M, HARTNETT T. A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatr Serv 2001;52:526-528.
35. SHANER A, Tucker DE, Roberts LJ, Eckman TA. Disability income, cocaine use and contingency management among cocaine dependent schizophrenic patients. In: HIGGINS ST, SILVERMAN K, eds. Motivating Behavior Change Among Illicit-Drug Abusers: Contemporary Research on Contingency Management Interventions. Washington, DC: American Psychological Association, 1999:95-122.
36. GREEN AI, ZIMMET SV, STROUS RD, SCHILDKRAUT JJ. Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Rev Psychiatry 1999;6:287-296.
37. MUESER KT, ROSENBERG SD. Treatment of posttraumatic stress disorder in persons with severe mental illness. In: WILSON JP, FRIEDMAN M, LINDY L, eds. Core Approaches for the Treatment of PTSD. New York, NY: Guilford Press, 2001:354-382.
38. MUESER KT, NOORDSY DL, FOX L, WOLFE R. Disulfiram treatment for alcoholism in severe mental illness. Am J Addictions 2003;12:242-252.
39. JERRELL JM, RIDGELY MS. Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatr Serv 1999;50:109-112.